About Convert Pharmaceuticals
Convert Pharmaceuticals is a public limited company (NV/SA) based in Liège, founded in 2017. Its main activity is classified as "Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied". For the 2025 financial year, Convert Pharmaceuticals reported a loss of €629,343. That makes 6 loss-making financial years in a row for Convert Pharmaceuticals. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€247,884. Equity is negative (-€841,823): liabilities exceed assets. In 2017 it was €944,062. 9 annual accounts are available, covering 2017 to 2025.
- Signals
-
Negative equityNegative equity € -842K
Equity is negative: debts exceed assets (technically insolvent).
Reporting lossesReporting losses € -629KThe company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.63The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -328KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -248KEBITDA is negative: operating activities are loss-making.
- Shareholders
- Noshaq 5,31%
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
-248K
|
€
-514K
|
€
-80K
|
€
78K
|
|
|
€
-248K
|
€
-518K
|
€
-147K
|
€
6K
|
|
|
€
-629K
|
€
-646K
|
€
-616K
|
€
-501K
|
|
|
€
-842K
|
€
-1.16M
|
€
-1.41M
|
€
-798K
|
|
|
-89.44%
|
-95.77%
|
-396.05%
|
-76.81%
|
|
|
€
1.78M
|
€
2.38M
|
€
1.77M
|
€
1.84M
|
|
|
€
158K
|
€
552K
|
€
75K
|
€
528K
|
Publications 8
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Siege Social - Demissions, Nominations 11/03/2020
- Demissions, Nominations 18/04/2019
- Demissions, Nominations 24/10/2017
- Siege Social 15/09/2017
- Capital, Actions - Statuts (Traduction, Coordination, Autres Modifications, ) 06/07/2017
Frequently asked questions
Answers to the most common questions about Convert Pharmaceuticals, based on official government data and the filed annual accounts.
What is the VAT number of Convert Pharmaceuticals?
The VAT number of Convert Pharmaceuticals is BE0671.828.631.
When was Convert Pharmaceuticals established?
Convert Pharmaceuticals was founded in 24-02-2017.
What is the official address of Convert Pharmaceuticals?
The official address of Convert Pharmaceuticals is Esplanade Simone Veil 1 Liège 4000.
What is the legal form of Convert Pharmaceuticals?
The juridical form of Convert Pharmaceuticals is Public limited company (NV/SA).
What is the annual revenue of Convert Pharmaceuticals?
The 2025 accounts of Convert Pharmaceuticals do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Convert Pharmaceuticals a reliable company?
Convert Pharmaceuticals is a registered Rechtspersoon with company number 0671.828.631 and can be verified through the official CBE database.
What is the credit limit of Convert Pharmaceuticals?
The estimated credit limit of Convert Pharmaceuticals is €0.
Is Convert Pharmaceuticals still active?
Convert Pharmaceuticals currently has the status "Normal situation" and is active.